Down-regulation_NN
of_IN
human_JJ
granzyme_NN
B_NN
expression_NN
by_IN
glucocorticoids_NNS
._.

Dexamethasone_NN
inhibits_VBZ
binding_NN
to_TO
the_DT
Ikaros_NN
and_CC
AP-1_NN
regulatory_JJ
elements_NNS
of_IN
the_DT
granzyme_NN
B_NN
promoter_NN
._.

The_DT
serine_NN
protease_NN
granzyme_NN
B_NN
is_VBZ
an_DT
essential_JJ
component_NN
of_IN
the_DT
granule_NN
exocytosis_NN
pathway_NN
,_,
a_DT
major_JJ
apoptotic_JJ
mechanism_NN
used_VBN
by_IN
cytotoxic_JJ
T_NN
lymphocytes_NNS
and_CC
natural_JJ
killer_NN
cells_NNS
to_TO
induce_VB
target_NN
cell_NN
apoptosis_NN
._.

Granzyme_NN
B_NN
gene_NN
transcription_NN
is_VBZ
induced_VBN
in_IN
activated_VBN
lymphocytes_NNS
upon_IN
antigenic_JJ
stimulation_NN
,_,
and_CC
several_JJ
regulatory_JJ
regions_NNS
including_VBG
CBF_NN
,_,
AP-1_NN
,_,
and_CC
Ikaros_NN
binding_NN
sites_NNS
have_VBP
been_VBN
shown_VBN
to_TO
be_VB
essential_JJ
in_IN
the_DT
control_NN
of_IN
granzyme_NN
B_NN
promoter_NN
activation_NN
._.

Dexamethasone_NN
,_,
a_DT
glucocorticoid_NN
that_WDT
is_VBZ
widely_RB
used_VBN
as_IN
an_DT
immunomodulatory_JJ
and_CC
anti-inflammatory_JJ
agent_NN
,_,
inhibits_VBZ
granzyme_NN
B_NN
mRNA_NN
transcript_NN
in_IN
phytohemagglutinin-activated_JJ
peripheral_JJ
blood_NN
mononuclear_JJ
cells_NNS
._.

Transfection_NN
of_IN
a_DT
reporter_NN
construct_NN
containing_VBG
the_DT
-148_CD
to_TO
+60_CD
region_NN
of_IN
the_DT
human_JJ
granzyme_NN
B_NN
promoter_NN
demonstrated_VBD
that_IN
this_DT
region_NN
was_VBD
the_DT
target_NN
for_IN
dexamethasone_NN
repression_NN
._.

Mutation_NN
of_IN
Ikaros_NN
or_CC
AP-1_NN
binding_NN
sites_NNS
in_IN
the_DT
context_NN
of_IN
the_DT
granzyme_NN
B_NN
promoter_NN
demonstrated_VBD
that_IN
both_DT
sites_NNS
participate_VBP
in_IN
dexamethasone-mediated_JJ
inhibition_NN
of_IN
the_DT
granzyme_NN
B_NN
promoter_NN
activity_NN
._.

Electromobility_NN
shift_NN
assay_NN
revealed_VBD
that_IN
dexamethasone_NN
abolished_VBD
the_DT
binding_NN
of_IN
nuclear_JJ
transcription_NN
factors_NNS
to_TO
the_DT
Ikaros_NN
binding_NN
site_NN
and_CC
reduced_VBD
AP-1_NN
binding_NN
activity_NN
._.

These_DT
results_NNS
indicate_VBP
that_IN
dexamethasone_NN
is_VBZ
able_JJ
to_TO
abrogate_VB
the_DT
transcriptional_JJ
activity_NN
of_IN
the_DT
human_JJ
granzyme_NN
B_NN
gene_NN
promoter_NN
by_IN
inhibiting_VBG
the_DT
binding_NN
of_IN
nuclear_JJ
factors_NNS
at_IN
the_DT
AP-1_NN
and_CC
Ikaros_NN
sites_NNS
._.

